As the foundation of pharmaceutical development and compliance, regulatory requirements are established to ensure and maintain two main pillars in assessing and qualifying API manufacturers: product quality and patient safety. If Active Pharmaceutical Ingredients (APIs) are not sourced or manufactured to meet regulatory standards, it can lead to product recalls, regulatory penalties, or even in worst case—patient harm.
When sourcing APIs, manufacturers can run into many challenges, including Paragraph IV and early launches in regulated markets. In the API supply chain, maintaining a reliable and compliant process is essential—from sourcing raw materials to ensuring that manufacturing partners meet regulatory requirements and have the necessary capacity to produce APIs at the required scale for clients.
In this article, we how to overcome API sourcing challenges and how APIs can be manufactured via non-infringing processes to manage cGMP compliance.
Do Your Research to Assess and Qualify API Manufacturers
To reduce risk and achieve product integrity, there are several key factors to consider:
- Regulatory Compliance: Complying with FDA, EMA, and/or other regulatory standards for approval
- Quality Assurance Systems: Documentation, traceability, and process control for product consistency and safety
- Manufacturing Capabilities: Demonstration of scalability, on-time deliveries, and maintaining quality standards
- Audit History and Track Record: Analyzing past performance, audit results, and certifications (ISO, GMP) to assess reliability
- Supply Chain Security: Ensuring raw materials are sourced ethically and securely to prevent contamination or shortages
The first step to assess and qualify API manufacturers and ensure they meet current Good Manufacturing Practices (cGMP) and regulatory requirements is checking to see if the manufacturer is USFDA registered. Following this, we review their regulatory history with the USFDA and other Western Regulator Authorities such as European and TFA. Our process also includes assessing geographical locations of the manufacturing, whether it’s Europe, Asia, or in the USA.
Common Risks in API Sourcing
-
Not Having a Full Understanding of Your Partner
One of the most common risks associated with API sourcing is not having a complete understanding of the partner that you are working with— especially if you haven’t visited their site. Having first-hand insight into a potential partner’s operations, capabilities, and regulatory compliance can help support a thorough evaluation to see if the company meets your standards and avoid issues or setbacks down the line.
-
Balancing Quality and Pricing
When sourcing APIs, balancing cost efficiency and quality can also be a challenge. But can you risk quality? LGM Pharma’s number one rule for API sourcing is that all quality requirements must be met. If a manufacturer does not meet the cGMP, it’s a hard and easy “no”, we will not work with that manufacturer. That being said, there is a balancing act between quality and cost efficiency that takes place.
Working with a manufacturer that can deliver the goods on time might mean looking at several sources. For every product LGM Pharma sources, we look at which is the most suitable manufacturer for our client needs to account for quality requirements and price demands for the product.
-
Meeting Different Regulatory Environments Across Regions
Across the global pharma industry, there are standard regulatory requirements. Any potential manufacturing or API sourcing company needs to meet meeting global requirements. Depending on the market you’re selling in, meeting regulatory requirements may fall under the FDA, EU GMP, and occasionally TDA or PMDA. With increasing demand for specialized API and niche APIs, LGM Pharma has specialized sourcing tools and teams to help navigate the different markets and identify manufactures for specific projects.
With Demand for Specialized APIs on the Rise, Trusted Networks are Everything
With tools and technology available in our modern world, there’s a growing emphasis on quality and safety which also fuels the need for specialized API sourcing. Pharmaceutical companies have to work hard to keep up with the expanding market—generics, niche therapies, and other personalized medicine. This demand drives a push for more APIs that are highly specific and tailored to meet consumer needs. Having a reliable, specialized partner with trusted capabilities is essential to make it in your market.
Another main challenge in sourcing niche APIs is ensuring a reliable manufacturer who meets 21 CFR and GMP requirements, and can commit to producing the API throughout the entire project lifecycle, from development to full commercialization.
At LGM Pharma, we have an extensive network of established API manufacturers with whom we’ve partnered with for almost 20 years. These manufacturers meet all regulatory standards, and in some cases, we can even request the production of niche products to meet unique project needs. Whenever possible, we prioritize working with manufacturers who already offer the API as part of their regular portfolio. This approach provides greater stability for the project, especially when multiple clients may require the same API.
The Future of API Sourcing
It’s been around for many years, but it’s still a hot topic and buzzword: Artificial Intelligence (AI). As AI continues to advance, we anticipate it will play an increasingly significant role in API sourcing. Ultimately, AI may even help identify which manufacturers are best suited to meet specific client needs, optimizing sourcing strategies. While this level of integration may be a while off, it’s exciting to envision AI’s potential in this space.
However, even with technological advances, building long-term human relationships remains essential. A strong, trusted partnership with manufacturers is still the backbone of successful API development, especially for projects that require years of collaboration before full commercialization.
At LGM Pharma, we’re committed to staying ahead of industry trends. We invest in new technologies to ensure we remain at the cutting edge of sourcing, so we’re properly positioned to meet our clients’ evolving needs.
How LGM Pharma Resolves API Sourcing Risks
To gain a bigger picture of any manufacturer when sourcing APIs, we check all information on: financial reports, how many employees they have, the number of products they are already manufacturing, countries they export to, partners they may work with, one site or multi-site locations, and much more. All of these factors are crucial to maintain trust with both regulators and patients—keeping the end result and goal in mind, gaining regulatory approval and keeping patients safe.
We mitigate these risks by planning visits and audits at every new potential manufacturer. This gives us a better understanding of the company and their manufacturing process. We also check multiple parameters to ensure we have a fully compliant manufacturing partner both from cGMP and business aspect.
Working closely with our manufacturing partners helps us to ensure compliance with all relevant standards, including ISO, GMP, and increasingly critical EHS (Environmental, Health, and Safety) requirements. EHS standards are growing in importance, with more clients prioritizing ethical sourcing practices that emphasize the safety, health, and well-being of workers, as well as environmentally sound operations. LGM Pharma is committed to partnering with manufacturers who share these values.
LGM Pharma conducts regular quality and business audits and maintain a comprehensive visit plan that includes both quality and business evaluations. These efforts help ensure our partners meet the high standards our clients expect, providing a transparent, ethical, and compliant supply chain for all APIs. Contact us to overcome your API sourcing headaches today.